Hitomi Motomura

Chuo, 2608675, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Analysis of vancomycin administration to patients with one kidney.

Analysis of vancomycin administration to patients with one kidney.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: June 20, 2025

Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells.

Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells.

Journal: Oncology letters

Published: July 23, 2023

High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer.

High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer.

Journal: Anticancer research

Published: August 07, 2022

High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.

High SLC20A1 Expression Is Associated With Poor Prognosis for Radiotherapy of Estrogen Receptor-positive Breast Cancer.

Journal: Cancer diagnosis & prognosis

Published: May 09, 2022

High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

Journal: Anticancer research

Published: May 09, 2022

High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.

High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer.

Journal: PloS one

Published: February 17, 2022

GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.

GLO 1 and PKCλ Regulate ALDH1-positive Breast Cancer Stem Cell Survival.

Journal: Anticancer research

Published: September 11, 2021

High SLC20A1 Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast Cancers.

High SLC20A1 Expression Is Associated With Poor Prognoses in Claudin-low and Basal-like Breast Cancers.

Journal: Anticancer research

Published: November 12, 2020

Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late-stage breast cancer.

Glyoxalase 1 and protein kinase Cλ as potential therapeutic targets for late-stage breast cancer.

Journal: Oncology letters

Published: September 02, 2020

High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.

High PKCλ expression is required for ALDH1-positive cancer stem cell function and indicates a poor clinical outcome in late-stage breast cancer patients.

Journal: PloS one

Published: November 27, 2019

High Expression of c-Met, PKCλ and ALDH1A3 Predicts a Poor Prognosis in Late-stage Breast Cancer.

High Expression of c-Met, PKCλ and ALDH1A3 Predicts a Poor Prognosis in Late-stage Breast Cancer.

Journal: Anticancer research

Published: November 13, 2019

Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells.

Glyoxalase 1 gene is highly expressed in basal-like human breast cancers and contributes to survival of ALDH1-positive breast cancer stem cells.

Journal: Oncotarget

Published: July 04, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026